This record was last updated December 22, 2025 (before its estimated March 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective, open-label, single-arm, exploratory clinical trial conducted at our institution to investigate the use of Irreversible Electroporation (IRE) for the treatment of breast cancer.
Protocol Amendment History
1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-24.
Status change: Not Yet Recruiting → Recruiting2025-12-16